Cell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistance.
about
Design of new acid-activated cell-penetrating peptides for tumor drug deliveryPolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery.MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression.The guanidinium unit in the catalysis of phosphoryl transfer reactions: from molecular spacers to nanostructured supports.Managing teenage/young adult (TYA) brain tumors: a UK perspective.The chemistry and biology of guanidine natural products.miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression.Nano-based strategies to overcome p-glycoprotein-mediated drug resistance.Peptide-drug conjugates as effective prodrug strategies for targeted delivery.Linker design for the modular assembly of multifunctional and targeted platinum(ii)-containing anticancer agents.Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells.Cross-Linking of Thiolated Paclitaxel-Oligo(p-phenylene vinylene) Conjugates Aggregates inside Tumor Cells Leads to "Chemical Locks" That Increase Drug Efficacy.Taking the vehicle out of drug delivery.Cell-penetrating peptide conjugates to enhance the antitumor effect of paclitaxel on drug-resistant lung cancer.The Current Role of Cell-Penetrating Peptides in Cancer Therapy.On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines
P2860
Q36398838-97962997-5D90-4E91-96E8-C6D3EA057116Q36980520-477AB815-3573-477A-9C20-874AEB0CA6F1Q37499235-9A66FB87-F8AE-4D42-937A-3AE6C4197DFDQ38458837-B85F84EC-59EB-4E92-B0DF-431EB3D26211Q38539466-AAE5D24E-0D76-4BEA-9991-F099C9659496Q38675089-1F6BF07A-44AB-4DE7-844C-FEB3B425DB27Q38795063-8FBEED9C-A949-43F9-B098-9AED83B42ADCQ38856533-3032EFC8-A587-4DE1-8302-AAEA42E09A0BQ38883760-613B8E2E-ADF4-4401-B91C-12844461B285Q41738179-04322DC4-8150-4072-AD14-E39DB9DA210BQ42118943-D547513E-C164-4DB4-8E8B-E616FC2BB1BFQ48228737-9E60B717-67BA-4FD6-BE40-3E33ED3C5F76Q50437586-59F99F28-65DE-4312-984E-607BA1FFD888Q50675888-4D03502C-FAC1-4CA1-91A6-7D73FC835DD5Q52450404-0C186118-06B5-4F97-BAC2-2D2B187F563EQ55054276-279EC71C-F216-4EB6-9D5E-0AA51991D260Q57073301-1694E91A-DB37-4808-B542-A9CC4F688202
P2860
Cell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistance.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cell-penetrating, guanidinium- ...... mediated multidrug resistance.
@ast
Cell-penetrating, guanidinium- ...... mediated multidrug resistance.
@en
Cell-penetrating, guanidinium- ...... mediated multidrug resistance.
@nl
type
label
Cell-penetrating, guanidinium- ...... mediated multidrug resistance.
@ast
Cell-penetrating, guanidinium- ...... mediated multidrug resistance.
@en
Cell-penetrating, guanidinium- ...... mediated multidrug resistance.
@nl
prefLabel
Cell-penetrating, guanidinium- ...... mediated multidrug resistance.
@ast
Cell-penetrating, guanidinium- ...... mediated multidrug resistance.
@en
Cell-penetrating, guanidinium- ...... mediated multidrug resistance.
@nl
P2093
P2860
P921
P356
P1476
Cell-penetrating, guanidinium- ...... mediated multidrug resistance.
@en
P2093
Erika Geihe Stanzl
Jessica R Vargas
Nelson N H Teng
Paul A Wender
P2860
P304
P356
10.1021/MP500161Z
P407
P577
2014-05-09T00:00:00Z
2014-08-04T00:00:00Z